February 2010
-
Staying with biotech
on
2010/02/21 by
Alex, [ETF,Exchange-traded funds]
Things have not changed much since last week, when we recommended putting some money into biotech. Both biotech and gold still look good, with biotech looking better than gold. All of the markets are that we follow remain so risky that we are keeping most of our money in the money market.
-
Small cap outperforming
on
2010/02/15 by
Alex, [TSP,Thrift Savings Plan]
The S Fund (“Extended Market”), which invests in small and medium cap stocks, appears to be outperforming the other two stock funds. However, as markets are still unstable, we are pulling out of stocks completely in our Conservative allocation.
-
A bit of biotech
on
2010/02/14 by
Alex, [ETF,Exchange-traded funds]
Both biotech and gold, which we recommended last week, look good, though biotech looks a little better for the coming week. Over the past week, both of these funds have made about 2.5%, compared with about 1.5% for large-cap stocks.
-
“Market timing could not be better”
on
2010/02/12 by
Alex, [Testimonials]
Peaceful, Your market timing could not be better. You I listen to. -C.N.
-
Trying gold again
on
2010/02/07 by
Alex, [ETF,Exchange-traded funds]
Though gold hasn’t moved since mid-December, we are trying it again as it, once again, appears to be the best option. Runners up include Malaysia and Consumer Staples.
-
What are good money market funds?
on
2010/02/01 by
Alex, [FAQ]
Question: I agree completely w/ moving funds into cash, as your latest newsletter recommends. I noticed the hyperlink for cash, and following it, see that “cash” means a money market fund w/ a 2% assumed return. Where are you banking? The money market funds are all returning the federal funds rate right now, about 0.1%. [...]